We have measured intra-ocular pressure (i.o.p.) in 20 patients anaesthetized with halothane or enflurane (0.6 MAC in oxygen) for repair of trauma to the eye. The changes in i.o.p. with halothane 0.5% were unpredictable, whereas enflurane 1% reduced intra-ocular tension consistently in all the patients studied. Enflurane is recommended as a possible alternative anaesthetic for surgery on the open eye.
0.5% (group 1) or enflurane 1% (group 2). These concentrations are approximately equivalent to 0.6 MAC in oxygen, and represent those commonly used to augment anaesthesia with nitrous oxide, oxygen and controlled mechanical ventilation. The anaesthetic agents were vaporized from two new vaporizers (Fluotec and Enfluratec: Cyprane Ltd, Mk III models).
Thirteen of the patients studied were to undergo evisceration and seven, attempted repair of a severely traumatized eye. The operations were performed electively, and the patients were in a normal state of hydration during investigation. After instillation of local anaesthetic solution into the conjunctival sac, the intra-ocular pressure of the patient's normal eye was measured before induction of anaesthesia, using a Perkins hand-held applantation tonometer (Perkins, 1965) .
Premedication comprised morphine 10-15 mg i.m. according to weight, together with diazepam 5 mg i.m. 1 h before operation. Anaesthesia was induced with thiopentone 4.5-5.5 mg kg" 1 and neuromuscular blockade was produced with pancuronium 0.1 mg kg"
1 . Pancuronium was chosen to prevent significant alteration of either i.o.p. (Al Abrak and Samuel, 1974b) or the haemodynamic state (Coleman et al., 1972) .
After manual ventilation with 40% oxygen in nitrous oxide by mask until adequate neuromuscular blockade had been achieved, the larynx was sprayed with 4 ml of lignocaine 4%, and the trachea was intubated. Thereafter, ventilation was controlled using a Manley ventilator delivering a minute volume of 120 ml kg" 1 . A constant inflation pressure of 2.5 kPa was used throughout the study.
The inspired oxygen concentration was maintained constant at 40% by monitoring the fresh gas flow with a Beckman OM 11 oxygen analyser and adjusting the flow rate of nitrous oxide and oxygen. The endtidal carbon dioxide concentration was monitored continuously with a Beckman LB2 infra-red carbon dioxide analyser and maintained at 5% by the addition of carbon dioxide to the fresh gas supply if necessary.
Central venous pressure (c.v.p.) was measured using a 16-gauge i.v. catheter which was inserted into the internal jugular vein after the patient had been anaesthetized. The surface of the operating table was used as the zero reference point for all c.v.p. measurements. Surgery was conducted with the patient in the horizontal position.
Recordings of heart rate and systolic arterial pressure were made at 5-min intervals. Both e.c.g. (standard lead I) and heart rate (photoelectric finger transducer) were displayed continuously on a Datascope 610 module. Systolic arterial pressure was measured using a sphygmomanometer.
The i.o.p., heart rate and systolic arterial pressure were recorded initially with the patient awake. These, together with c.v.p. measurements, were repeated 10 and 15 min after the injection of thiopentone. Stable conditions were produced in all patients within 15 min of the induction of anaesthesia.
Thereafter, either enflurane 1% or halothane 0.5% vapour was added to the inspired gas mixture and i.o.p., heart rate, systolic arterial pressure and c.v.p. were recorded at 5,10 and 15 min following the introduction of the volatile anaesthetic. Stable conditions were achieved again in every patient within 15 min.
After completion of the study surgery was commenced on the traumatized eye. At the conclusion of the operation, residual neuromuscular blockade was antagonized with neostigmine 3.75 mg, i.v. preceded by atropine 1.2 mg.
The results were analysed using a Student's paired t test for significant difference between two sample means, computed on a Hewlett-Packard (9815 A) desk calculator.
RESULTS
The two groups of patients studied were similar with respect to age (halothane group 29.2 yr + 7.7 (mean ± SD), enflurane 27.8 yr ± 7.3) and body weight (halothane group 55.6 kg ±13.9, enflurane 610ke ±11.2).
Induction of anaesthesia and controlled ventilation decreased i.o.p. in both groups, but the changes were statistically significant only in group 1 (figs 1, 2) . The addition of 0.5% halothane to the inspired gas mixture produced, after 15min } a further but The mean heart rate before anaesthesia was slightly greater in group 2, a pattern which persisted throughout the study. Heart rate increased in both groups following induction of anaesthesia, but the change was significant only in group 1. The addition of a volatile anaesthetic to the inspired gas reduced heart rate significantly in both groups (figs 1, 2).
Mean arterial pressure changed little following induction of anaesthesia, but both halothane and enflurane caused significant decreases in mean arterial pressure (P<0.05 and P<0.01 respectively).
Central venous pressure was unchanged throughout anaesthesia in both groups. heart rate before and after enflurane 1%.
DISCUSSION
The effects of halothane on i.o.p. are well documented (Al Abrak and Samuel, 1974a) , but similar studies with enflurane are limited in their scope. A previous investigation of enflurane (Radtke and Waldman, 1975) failed to standardize the various factors which influence i.o.p. during general anaesthesia. These include alterations in arterial carbon dioxide tension, inspired oxygen concentration, arterial and central venous pressures and the premedication and anaesthetic technique used (Al Abrak and Samuel 1974a; Duncalf, 1975; Macdiarmid and Holloway, 1976 ). The present study followed the design of that by Al Abrak and Samuel (1974a) and utilized pancuronium which is known not to influence i.o.p. significantly (Al Abrak and Samuel, 1974b) , or cardiovascular haemodynamics (Coleman et al., 1972) . Applanation tonometry was used to measure i.o.p. as this technique has been found to be both accurate and reliable in previous studies of i.o.p. changes during general anaesthesia (Al Abrak and Samuel, 1975; Radtke and Waldman, 1975) . Radtke and Waldman (1975) , in a study conducted on young, healthy patients breathing 3-5% enflurane spontaneously, reported a significant decrease in mean i.o.p. of 4 mm Hg (0.53 kPa). In this investigation, controlled ventilation with 1% enflurane reduced i.o.p. in every patient of group 2, thus resulting in a significant decrease in mean i.o.p. of 0.48 kPa (P<0.01). In contrast, halothane failed to alter mean i.o.p. significantly (group 1) and produced varying effects in individual patients (i.o.p., increased in two, did not alter in three and decreased in five patients). The degree of change in i.o.p. induced by enflurane was thus greater than that caused by an equipotent concentration of halothane (approximately 0.6 m.a.c. in oxygen).
The possible mechanisms whereby anaesthetic drugs reduce i.o.p. under controlled conditions include relaxation of intra-ocular and extra-ocular muscles, facilitation of the flow of aqueous humour, or decrease in production of aqueous humour (Duncalf, 1975) . Both halothane and especially enflurane actively inhibit neuromuscular conduction. Furthermore, all inhalation anaesthetic agents are alleged to reduce i.o.p. by facilitation of aqueous flow (Duncalf, 1975) , and enflurane may be expected to possess a similar action.
Before drawing any conclusions from this study, we should comment on certain findings. The initial decrease in i.o.p. from pre-induction control values before the administration of the volatile agent was greater in group 1 than in group 2. However, mean i.o.p. 15 min after the introduction of the volatile agent was significantly less (P< 0.005) in group 2 (enflurane) compared with group 1 (halothane), despite similar i.o.p. values before the induction of anaesthesia. Other factors which may have influenced our results include the presence of a slightly greater mean systolic arterial pressure during anaesthesia in the halothane group, but heart rates were faster in the patients receiving enflurane.
Finally, the exact concentrations of halothane and enflurane delivered by their respective vaporizers were not measured. The vaporizers used were relatively new and recently calibrated, but their accuracy during anaesthesia was not established (Al Abrak and Samuel, 1974a) .
However, we can conclude from this study that enflurane 1%, in combination with nitrous oxide, oxygen, muscle relaxation and controlled mechanical ventilation, decreases i.o.p. significantly. Enflurane appears to offer a reasonable alternative to halothane for use in ophthalmic anaesthesia.
